Community antibiotic prescriptions for the 211 patients exposed in the 2 weeks prior to admission with COVID-19
| Number of prescriptions dispensed (%) | |
| One antibiotic (n=187) | |
| Amoxicillin | 56 (25.3) |
| Azithromycin | 1 (0.5) |
| Cephalexin | 4 (1.8) |
| Clarithromycin | 15 (6.8) |
| Co-amoxiclav | 27 (12.2) |
| Doxycycline | 24 (10.9) |
| Erythromycin | 1 (0.5) |
| Flucloxacillin | 6 (2.7) |
| Metronidazole | 1 (0.5) |
| Nitrofurantoin | 23 (10.4) |
| Trimethoprim | 4 (1.8) |
| Unknown | 25 (11.3) |
| Two antibiotics (n=30) | |
| Amoxicillin+clarithromycin | 6 (2.7) |
| Amoxicillin+co-amoxiclav | 3 (1.4) |
| Amoxicillin+doxycycline | 5 (2.3) |
| Amoxicillin+flucloxacillin | 2 (0.9) |
| Amoxicillin+nitrofurantoin | 4 (1.8) |
| Co-amoxiclav+nitrofurantoin | 3 (1.4) |
| Co-amoxiclav+ciprofloxacin | 1 (0.5) |
| Co-amoxiclav+clarithromycin | 1 (0.5) |
| Co-amoxiclav+doxycycline | 1 (0.5) |
| Co-amoxiclav+erythromycin | 1 (0.5) |
| Co-amoxiclav+flucloxacillin | 1 (0.5) |
| Doxycycline+ciprofloxacin | 1 (0.5) |
| Doxycycline+clarithromycin | 1 (0.5) |
| Three or more antibiotics (n=4) | |
| Amoxicillin+clarithromycin+metronidazole | 1 (0.5) |
| Amoxicillin+clarithromycin+nitrofurantoin | 1 (0.5) |
| Co-amoxiclav+clarithromycin+doxycycline | 1 (0.5) |
| Co-amoxiclav+ciprofloxacin+nitrofurantoin | 1 (0.5) |